Executive Officer
 |
Ivana Magovčević-Liebisch, PhD, JDExecutive Vice President and Chief Business Officer
Dr. Magovcevic-Liebisch is Dyax's Executive Vice President and Chief Business Officer and has served as an executive officer of the Company since December 2005. In addition to overseeing all aspects of Commercial Operations, she also manages Business Development, Alliance Management and Legal Affairs. She joined Dyax in April 2001 as Vice President of Intellectual Property and has held several different positions within the Company. Dr. Magovcevic-Liebisch was Director of Intellectual Property and Patent Counsel for Transkaryotic Therapies, Inc. from 1998 to 2001. Dr. Magovcevic-Liebisch holds a doctorate in genetics from Harvard University and a law degree from Suffolk University. |